Handling uncertainty in dynamic models: the pentose phosphate pathway in Trypanosoma brucei. Kerkhoven, E.J.; Achcar, F.; Alibu, V. P.; Burchmore, R. J; Gilbert, I. H.; Trybiło, M.; Driessen, N. N.; Gilbert, D.; Breitling, R.; Bakker, B. M.; Barrett, M. P. PLoS Comput. Biol., 2013, 9, e1003371.

Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. Pizarro, J.; Hills, T.; Senisterra, G.; Wernimont, A.; MacKenzie, C. J.; Norcross, N.; Ferguson, M. A. J.; Wyatt, P. G.; Gilbert, I. H.; Hui, R. Plos. Negl. Trop. Dis. 2013, 7, e2492.

Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches, Gilbert, I. H. J. Med. Chem., 2013, 56, 7719-7726.

Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor. Kahsai, A. W.; Wingler, L. M.; Zhu, X.; Tripathi-Shukla, P.; Huang, X.-P.; Riley, J.; Besnard, J.; Read, K. D.; Roth, B. L.; Gilbert, I. H.; Hopkins, A. L.; Lefkowitz, R. J.; Navratilova, I. ACS Med. Chem. Lett., 2013, 4, 1005-1010.

Structure-Activity Relationship Studies of Pyrrolone Antimalarial Agents. Murugesan, D.; Kaiser, M.; White, K. L.; Norval, S.; Riley, J.; Wyatt, P. G.; Charman, S. A.; Read, K. D.; Yeates, C.; Gilbert, I. H. ChemMedChem, 2013, 8, 1537-1544.

Investigation of acyclic uridine amide and 5’-amido nucleoside analogues as potential inhibitors of the Plasodium falciparum dUTPase. Hampton, S. E.; Schipani, A.; Bosch-Navarrete, C.; Recio, E.; Kaiser, M.; Kahnberg, P.; González-Pacanowska, D.; Johansson, N. G.; Gilbert, I. H. Bioorg. Med. Chem., 2013, 21, 5876-5885.

Fragment-based hit identification: thinking in 3D. Morley, A. D.; Pugliese, A.; Birchall, K.; Bower, J.; Brennan, P.; Brown, N.; Chapman, T.; Drysdale, M.; Gilbert, I. H.; Hoelder, S.; Jordan, A.; Ley, S. V.; Merritt, A.; Miller, D.; Swarbrick, M. E.; Wyatt, P. G. Drug Discov Today. 2013, 18, 1221-1227.  

From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules. Woodland A, Grimaldi R, Luksch T, Cleghorn LA, Ojo KK, Van Voorhis WC, Brenk R, Frearson JA, Gilbert IH, Wyatt PG. ChemMedChem. 2013 Jul;8(7):1127-37.    

Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay. De Rycker M, Hallyburton I, Thomas J, Campbell L, Wyllie S, Joshi D, Cameron S, Gilbert IH, Wyatt PG, Frearson JA, Fairlamb AH, Gray DW. Antimicrob Agents Chemother. 2013 Jul;57(7):2913-22.    

Discovery and structure-activity relationships of pyrrolone antimalarials. Murugesan D, Mital A, Kaiser M, Shackleford DM, Morizzi J, Katneni K, Campbell M, Hudson A, Charman SA, Yeates C, Gilbert IH. J Med Chem. 2013 Apr 11;56(7):2975-90.